picoplatin
information and resources from the National Cancer Institute
NCI Thesaurus | picoplatin
A new generation organic platinum analog with an extended spectrum of antineoplastic activity. Designed to overcome platinum drug resistance, picoplatin alkylates DNA, forming both inter- and intra-strand cross-linkages, resulting in inhibition of DNA replication and transcription, and the induction of apoptosis. NCI Thesaurus | picoplatin
A new generation organic platinum analog with an extended spectrum of antineoplastic activity. Designed to overcome platinum drug resistance, picoplatin alkylates DNA, forming both inter- and intra-strand cross-linkages, resulting in inhibition of DNA replication and transcription, and the induction of apoptosis.
|
|
|
|
news articles
NeoRx Announces Orphan Drug Designation for Picoplatin for ... Nov 10, 2005
Yahoo! News (press release) ...designation from the Office of Orphan Products Development at the US Food and Drug Administration for the Company's investigational product picoplatin, a next ...
NeoRx Reports Third Quarter 2005 Financial Results Nov 9, 2005
Yahoo! News (press release) Began treating patients with picoplatin, a next-generation platinum therapy, in a Phase II clinical trial in small cell lung cancer. ...
Korean firm ends antitrust dispute Nov 11, 2005
Seattle Times, NeoRx's experimental treatment for small-cell lung cancer, picoplatin, was designated an "orphan drug" by federal regulators, the Seattle company said Thursday ...
NeoRx cancer treatment to receive priority review Nov 10, 2005
Puget Sound Business Journal, Seattle-based NeoRx (NASDAQ: NERX) is conducting a phase two clinical trial of picoplatin as a treatment for small-cell lung cancer at 25 clinics in the United ...
NeoRx to Present at Rodman & Renshaw Techvest Healthcare ... Nov 1, 2005
PharmaLive.com (press release), Dr. McMahon will provide an update on the ongoing Phase II trial of picoplatin, a next-generation platinum therapy, in patients with small cell lung cancer. ...
NeoRx executives seeking cash as biotechnology firm runs short Nov 10, 2005
Seattle Post Intelligencer Money also would be funneled to develop picoplatin, a therapy designed to treat solid tumors, including small-cell lung cancer. ...
Technology Briefing Nov 10, 2005
Seattle Post Intelligencer ...has received orphan drug status from the Food and Drug Administration for picoplatin, its experimental treatment for small-cell lung cancer. ...
Highlights of rising and falling US stocks Nov 10, 2005
Investor's Business Daily (subscription) ...(NERX) ran up by as much as 9.6% after saying the US Food and Drug Administration has granted it orphan drug designation for its Picoplatin platinum therapy ...
Pulso de mercado Nov 10, 2005
Bolsamania.com, ...[+]. (PRN) - HBO Films' Oscar(R)-Nominated 'YESTERDAY' About AIDS in... [+. PRN) - NeoRx Announces Orphan Drug Designation for Picoplatin for... [+.
(PRN) - U-Haul Supports Veterans as a Key Sponsor of the 2005 ... Nov 10, 2005
Bolsamania.com, November 10 ... [+. PRN) - NeoRx Announces Orphan Drug Designation for Picoplatin for Treatment of Small Cell Lung Cancer ... [+. PRN ...
|
|
